desipramine has been researched along with Inborn Errors of Metabolism in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Her elimination half-life for desipramine was found to be greatly prolonged, at approximately 150 hours." | 1.27 | Idiosyncratic pharmacokinetics complicating treatment of major depression in an elderly woman. ( Dugas, JE; Glassman, JN; Loyd, DW; Tsuang, MT, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glassman, JN | 1 |
| Dugas, JE | 1 |
| Tsuang, MT | 1 |
| Loyd, DW | 1 |
1 other study available for desipramine and Inborn Errors of Metabolism
| Article | Year |
|---|---|
Idiosyncratic pharmacokinetics complicating treatment of major depression in an elderly woman.
Topics: Depressive Disorder; Desipramine; Diphenhydramine; Female; Half-Life; Hospitalization; Humans; Kinet | 1985 |